Similar companies
Related EMIS Industry Reports
Hyundai Feed Inc., located in Cheonan, is a company that was established in 1983. They specialize in the production of various immuno-oncology therapies for ovarian, pancreatic, and metastatic breast cancer. Their flagship product, FLORA-5 (oregovomab), an ovarian cancer drug, is currently undergoing FDA global Phase 3 clinical trials after showing promising results in Phase 2 trials. The company aims to develop breakthrough anti-cancer drugs to improve the lives of cancer patients. Throughout their history, Hyundai Feed Inc. has achieved various milestones such as obtaining HACCP certification, expanding production facilities, and being listed on KOSDAQ. They continue to prioritize research and development to create human-friendly immuno-oncology drugs that protect the nobility of life.
Headquarters
23, Yongsugol-Gil, Dongnam-Gu, Cheonan-Si, Chungcheongnam-Do
Cheonan; Chungcheongnam;
Contact Details: Purchase the Hyundai Feed Inc. report to view the information.
Website: http://www.hdfeed.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service
